LillyDirect Foundayo vs Ro
LillyDirect Foundayo and Ro both sell orforglipron; this is how their prices, coverage and records differ.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
LillyDirect Foundayo
Best for: oral orforglipron alongside the injectables
Visit LillyDirect Foundayo →
Ro
Best for: knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC
Visit Ro →If you are choosing between LillyDirect Foundayo and Ro, price alone will not settle it. Both prescribe orforglipron, so moving from one to the other would not change your drug. LillyDirect Foundayo leads our six-part score, 7.2 to 6.7.
LillyDirect Foundayo vs Ro price
LillyDirect Foundayo and Ro start at the same figure, $149 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.
Drug by drug: Orforglipron costs the same at both, $149 a month.
Medications and formats
Both sell orforglipron.
On format they match: each offers brand-name pens.
Where each one treats patients
LillyDirect Foundayo lists 51 states, and Ro does not publish where it ships.
Pricing
LillyDirect Foundayo
Requires commercial insurance; Medicare/Medicaid not eligible. 'Starting at $25 per month'.
Regular self-pay price, 1-month (30-day) supply.
Regular self-pay price, 1-month supply.
Regular self-pay price, 1-month supply.
Regular self-pay price $349; available for $299 via an automatic purchase offer ONLY if you complete your refill within 45 days of the delivery/receipt date of your previous Foundayo fill (14.5/17.2 mg only).
Ro
Additional membership fees apply
What each price covers
Ro's price also covers the clinician visit, lab work and coaching, which LillyDirect Foundayo does not claim.
LillyDirect Foundayo does not say what its price includes.
Ro is silent on shipping.
LillyDirect Foundayo
Inclusions not disclosed.
Ro
Covered by the monthly price
Medication
Charged on top
Clinician visits
In the price
Shipping
Not stated
Lab work
In the price
Coaching
In the price
Where each one scores higher
Overall, LillyDirect Foundayo scores 7.2 and Ro 6.7 out of 10.
LillyDirect Foundayo is stronger on trust & safety (8.5 vs 8.0) and accessibility (10.0 vs 5.0).
Ro is stronger on support (5.5 vs 5.0).
Value, effectiveness and user experience are within half a point.
LillyDirect Foundayo
7.2/10
Ro
6.7/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither LillyDirect Foundayo nor Ro has an FDA warning letter on record with us.
Features & Coverage
| Feature | LillyDirect Foundayo | Ro |
|---|---|---|
| Starting Price | $149/mo | $149/mo |
| Features | 5 features | ✓7 features |
| States Available | 51 | Not disclosed |
| Compounded | — | — |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About LillyDirect Foundayo
Any licensed prescriber can write it, but LillyDirect will not ship without a valid US prescription. Eli Lilly runs this channel itself, direct-pay, and what it sells is Foundayo (orforglipron): for weight loss, the first oral GLP-1 pill. Commercially insured patients holding the Lilly Savings Card pay $25/month. Paying cash costs $149-$299/month, depending on labeled dose.
Read our full LillyDirect Foundayo review →About Ro
Foundayo (orforglipron), the new oral GLP-1 from Eli Lilly, joined Ro on April 9 2026 at $149/month for the lowest dose, membership on top. Beside it sit compounded semaglutide and the brand-name pair, Zepbound and Wegovy. No obesity care formulary in the category is more comprehensive. In the US, only a handful of direct-to-patient telehealth companies are larger.
Read our full Ro review →Pros & Cons
LillyDirect Foundayo
What we like
- Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- Serves all 50 states
- We found no FDA warning letters issued to LillyDirect Foundayo
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Ro
What we like
- Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes clinician visits, lab work and coaching
- Names Roman Health Pharmacy LLC as the pharmacy that fills its prescriptions, which most sellers do not
- We found no FDA warning letters issued to Ro
Watch-outs
- Not included in the monthly price: medication
- Confirm it serves your state before you start the intake
Our Verdict
LillyDirect Foundayo wins this one, 7.2 to 6.7, above all for oral orforglipron alongside the injectables. Ro fits better if knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC is your priority.
Choose LillyDirect Foundayo if…
You want oral orforglipron alongside the injectables and an opening price near $149 a month.
Choose Ro if…
You want knowing which pharmacy fills the vial: it names Roman Health Pharmacy LLC and an opening price near $149 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Wellorithm
Compounded semaglutide at $247/month
From $247/mo
Get started →Willow
Seeing what it charges before you answer any medical questions
From $299/mo
Get started →Sesame Care
Oral orforglipron alongside the injectables
From $59/mo
Get started →LillyDirect Foundayo vs Ro: FAQ
Close alternatives to LillyDirect Foundayo and Ro
- LillyDirect Foundayo vs Amazon One Medical
- LillyDirect Foundayo vs GoodRx
- LillyDirect Foundayo vs Found
- Ro vs Amazon One Medical
- Ro vs GoodRx
- Ro vs Found
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.